PH24950A - Pyrrolidine derivatives and pharmaceutical compositions containing the same - Google Patents

Pyrrolidine derivatives and pharmaceutical compositions containing the same

Info

Publication number
PH24950A
PH24950A PH36844A PH36844A PH24950A PH 24950 A PH24950 A PH 24950A PH 36844 A PH36844 A PH 36844A PH 36844 A PH36844 A PH 36844A PH 24950 A PH24950 A PH 24950A
Authority
PH
Philippines
Prior art keywords
same
pharmaceutical compositions
compositions containing
pyrrolidine derivatives
pyrrolidine
Prior art date
Application number
PH36844A
Other languages
English (en)
Inventor
Hiroyuki Setoi
Hideo Hirai
Hiroshi Marusawa
Akio Kuroda
Hirokazu Tanaka
Masashi Hashimoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878710352A external-priority patent/GB8710352D0/en
Priority claimed from GB878716438A external-priority patent/GB8716438D0/en
Priority claimed from GB878730027A external-priority patent/GB8730027D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PH24950A publication Critical patent/PH24950A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
PH36844A 1987-05-01 1988-04-26 Pyrrolidine derivatives and pharmaceutical compositions containing the same PH24950A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878710352A GB8710352D0 (en) 1987-05-01 1987-05-01 Pyrrolidine derivatives
GB878716438A GB8716438D0 (en) 1987-07-13 1987-07-13 Pyrrolidine derivatives
GB878730027A GB8730027D0 (en) 1987-12-23 1987-12-23 Pyrrolidine derivatives

Publications (1)

Publication Number Publication Date
PH24950A true PH24950A (en) 1990-12-26

Family

ID=27263412

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36844A PH24950A (en) 1987-05-01 1988-04-26 Pyrrolidine derivatives and pharmaceutical compositions containing the same

Country Status (18)

Country Link
US (1) US4916152A (es)
EP (1) EP0289911B1 (es)
JP (1) JPS63295553A (es)
KR (1) KR970005190B1 (es)
CN (1) CN1020899C (es)
AR (1) AR247879A1 (es)
AU (1) AU613360B2 (es)
CA (1) CA1329391C (es)
DE (1) DE3881755T2 (es)
DK (1) DK233888A (es)
ES (1) ES2054729T3 (es)
FI (1) FI88716C (es)
HU (1) HU208671B (es)
IE (1) IE62862B1 (es)
IL (1) IL86173A (es)
NO (1) NO173330C (es)
PH (1) PH24950A (es)
PT (1) PT87359B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130323A (en) * 1988-10-31 1992-07-14 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
US5264453A (en) * 1988-10-31 1993-11-23 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
FR2685325B1 (fr) * 1991-12-20 1994-02-04 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2687146B1 (fr) * 1992-02-12 1994-04-01 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
RU94046180A (ru) * 1992-07-02 1996-10-27 Фудзисава Фармасьютикал Ко. Способ получения производного пирролидина и его соли, исходный продукт и способ его получения
KR100671658B1 (ko) 2005-01-05 2007-01-19 삼성에스디아이 주식회사 마스크 프레임 및 이를 사용한 마스크 고정방법
CA3043911A1 (en) * 2007-12-04 2009-07-02 Arbutus Biopharma Corporation Targeting lipids
CN109912487B (zh) * 2019-03-25 2023-01-10 山东理工大学 一种合成1-对甲苯磺酰基-2-乙烯基-1氢-吡咯的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577440A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-amido-pyrrolidines
US4282243A (en) * 1972-04-03 1981-08-04 A. H. Robins Company, Inc. Optical isomers of 4-amino-N-(1-cyclohexyl-3-pyrrolidinyl)-N-methylbenzamide
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
DE3165669D1 (en) * 1980-06-23 1984-09-27 Squibb & Sons Inc Azido, imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids having hypotensive activity
GB8509703D0 (en) * 1985-04-16 1985-05-22 Fujisawa Pharmaceutical Co Pyrrolidine derivatives
US4785119A (en) * 1985-10-11 1988-11-15 Tokyo Kasei Kogyo Co., Ltd. 3-aminopyrrolidine compound and process for preparation thereof
JPH07108898B2 (ja) * 1986-08-20 1995-11-22 大日本製薬株式会社 3−アミノピロリジン誘導体およびその塩の製造法
US5130323A (en) * 1988-10-31 1992-07-14 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives

Also Published As

Publication number Publication date
JPS63295553A (ja) 1988-12-01
IL86173A (en) 1992-02-16
CN1020899C (zh) 1993-05-26
FI882015A0 (fi) 1988-04-29
DE3881755T2 (de) 1993-10-21
NO173330C (no) 1993-12-01
HU208671B (en) 1993-12-28
HUT48579A (en) 1989-06-28
FI882015A (fi) 1988-11-02
AU613360B2 (en) 1991-08-01
AR247879A1 (es) 1995-04-28
DK233888D0 (da) 1988-04-28
NO173330B (no) 1993-08-23
DE3881755D1 (de) 1993-07-22
CN88102511A (zh) 1988-11-23
DK233888A (da) 1988-11-02
EP0289911B1 (en) 1993-06-16
FI88716C (fi) 1993-06-28
CA1329391C (en) 1994-05-10
NO881884L (no) 1988-11-02
EP0289911A3 (en) 1989-08-16
US4916152A (en) 1990-04-10
EP0289911A2 (en) 1988-11-09
KR970005190B1 (ko) 1997-04-14
AU1534888A (en) 1988-11-03
FI88716B (fi) 1993-03-15
PT87359A (pt) 1989-05-31
ES2054729T3 (es) 1994-08-16
KR880013889A (ko) 1988-12-22
NO881884D0 (no) 1988-04-29
JPH0546335B2 (es) 1993-07-13
IE881260L (en) 1988-11-01
IL86173A0 (en) 1988-11-15
PT87359B (pt) 1992-08-31
IE62862B1 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
IL87116A (en) 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
PH25932A (en) Adenosine derivatives and pharmaceutical compositions containing the same
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
NZ224347A (en) Heterocyclic compounds and pharmaceutical compositions
NZ226481A (en) Dideoxycytidine derivatives and pharmaceutical compositions
NZ224207A (en) Substituted pyrroles and pharmaceutical compositions
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
IL89502A0 (en) Plantinum derivatives and pharmaceutical compositions containing the same
IL86081A0 (en) Benzazepine derivatives and pharmaceutical compositions containing the same
GB8825892D0 (en) Pharmaceutical composition
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
NZ227297A (en) Heterocyclyl-substituted pyrrolidine derivatives and pharmaceutical compositions
NZ224181A (en) Pyrrolidine derivatives and pharmaceutical compositions
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
PH24950A (en) Pyrrolidine derivatives and pharmaceutical compositions containing the same
IL80668A0 (en) Benzazepine derivatives and pharmaceutical compositions containing the same
NZ223051A (en) Carbamoyloxylabdane derivatives and pharmaceutical compositions
NZ226738A (en) Ginkgolide derivatives and pharmaceutical compositions
ZA893422B (en) Pharmaceutical composition
IL92650A0 (en) Polyhydroxybenzyloxypropanolamides and pharmaceutical compositions containing them